# Jasper Therapeutics, Inc.: Form 8-K, filed Oct 20, 2023

- Company: [Jasper Therapeutics, Inc.](/companies/jspr.md) (CIK 1788028)
- Form: 8-K
- Filed: 2023-10-20
- Accepted by EDGAR: Oct 20, 2023, 06:04 ET
- Period: 2023-10-18
- Accession: 0001013762-23-005230
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1788028/000101376223005230/ea186965-8k_jasper.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1788028/000101376223005230/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1788028/000101376223005230/ea186965-8k_jasper.htm

Filed Oct 20, 2023.
Source: SEC EDGAR, the filing index for accession 0001013762-23-005230. Last ingested by Listed: Nov 4, 2026, 08:12 ET. No prices; not investment advice.